The 340B Program: A Shifting Landscape - June 26, 2026

 

 

Target Audience

Physicians and Pharmacists

Learning Objectives

At the end of this activity, the learner or the healthcare team should be able to:

  • Review the changing landscape of the 340B program, including the history of the program, current requirements for participation, and program growth.
  • Understand the Alternative Dispute Resolution (ADR) process and HRSA’s authority to oversee disputes between covered entities and manufacturers.
  • Learn about changing federal landscape regarding manufacturer restrictions on the use contract pharmacies and the current state of legal challenges.
  • Evaluate the implications of manufacturer rebate policies, including ongoing litigation on rebates, and HRSA’s pilot program for the use of manufacturer rebates to provide 340B discounts in limited instances.
  • Understand trends in state policies impacting the 340B program and discuss the potential for similar efforts in Massachusetts.
Course summary
Available credit: 
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 2.00 MA Risk Management
  • 1.50 Participation
Course opens: 
06/26/2026
Course expires: 
08/26/2026
Rating: 
0

BU CCE Program Manager: Naomi Moeller


In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and the Massachusetts League of Community Health Centers. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physicians
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists

This activity is approved for 1.50 CPE credit(s) under the ACPE universal activity number UAN JA0000185-9999-26-047-L03-P. The activity is available for credit claiming through August 26, 2026.

Available Credit

  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 2.00 MA Risk Management
  • 1.50 Participation
Please login or register to take this course.